Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, Sader R, Kirkpatrick C, Choukroun J.
Advanced platelet-rich brin: a new concept for cell-based tissue engineering by means of in ammatory cells.
J Oral Implantol. 2014 Dec;40(6):679-89.
Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbé G, Del Corso M, Inchingolo F, Sammartino G.
Do the brin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence- based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich brin (L-PRF).
Curr Pharm Biotechnol. 2012 Jun;13(7):1145-52.
Anitua E, Zalduendo MM, Prado R, Alkhraisat MH, Orive G.
Morphogen and proin ammatory cytokine release kinetics from PRGF-Endoret brin sca olds: evaluation of the effect of leukocyte inclusion.
J Biomed Mater Res A. 2015 Mar;103(3):1011-20.
Anitua E, Zalduendo M, Troya M, Orive G.
PRGF exerts a cytoprotective role in zoledronic acid-treated
oral cells.
Clin Oral Investig. 2015 Jul 23. [Epub ahead of print]
Passaretti F, Tia M, D’Esposito V, De Pascale M, Del Corso M, Sepulveres R, Liguoro D, Valentino R, Beguinot F, Formisano P, Sammartino G.
Growth-promoting action and growth factor release by different platelet derivatives.
Platelets. 2014;25(4):252-6.
Schär MO, Diaz-Romero J, Kohl S, Zumstein MA, Nesic D.
Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
Clin Orthop Relat Res. 2015 May;473(5):1635-43.
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T.
Classi cation of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich brin (L-PRF). Trends Biotechnol. 2009 Mar;27(3):158-67.
Suárez-López Del Amo F, Monje A, Padial-Molina M, Tang Z, Wang HL.
Biologic Agents for Periodontal Regeneration and Implant Site Development.
Biomed Res Int. 2015;2015:957518.
Davis VL, Abukabda AB, Radio NM, Witt-Enderby PA, Clafshenkel WP, Cairone JV, Rutkowski JL.
Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria.
J Oral Implantol. 2014 Aug;40(4):511-21.
Davis VL, Abukabda AB, Radio NM, Witt-Enderby PA, Clafshenkel WP, Cairone JV, Rutkowski JL.
Platelet-rich preparations to improve healing. Part I: workable options for every size practice.
J Oral Implantol. 2014 Aug;40(4):500-10.
